Table 1

Baseline characteristics of study population (n=67)

Patient characteristics
  Age, years74±7
 Female36 (54%)
 Hypertension41 (61%)
 Diabetes mellitus16 (24%)
 Stroke/TIA/thromboembolism37 (55%)
 Vascular disease11 (16%)
 Congestive heart failure5 (7%)
 Abnormal liver function1 (1%)
 Abnormal renal function9 (13%)
 Labile INRs2 (3%)
 Indication for antithrombotic medication17 (25%)
 Alcohol3 (4%)
 CHA2DS2-VASc score3.0±1.6
 HAS-BLED score2.7±0.9
Procedural characteristics
 Anaesthesia/intraprocedural imaging
  G.A. with TEE guidance28 (42%)
  L.A. with ICE guidance39 (57%)
  LAA closure device
  Amulet44 (66%)
  Watchman11 (16%)
  WatchmanFLX12 (18%)
 Procedure time (min)46 ± 13
 Contrast volume (mL)135 ± 42
Postprocedural medication
 Single antiplatelet agent4 (6%)
 Double antiplatelet therapy63 (94%)
 Oral anticoagulation
  • G.A, general anaesthesia; ICE, intracardiac echocardiography; INR, international normalised ratio; L.A, local anaesthesia; LAA, left atrial appendage; TEE, transoesophageal echocardiography; TIA, transient ischaemic attack.